Prolonged antibiotic therapy increases risk of infection after transrectal prostate biopsy: a case report after pancreasectomy and review of the literature

Arch Ital Urol Androl. 2014 Dec 30;86(4):387-8. doi: 10.4081/aiua.2014.4.387.

Abstract

Infection due to prostate biopsy afflicted more than 5% of patients and is the most common reason for hospitalization. A large series from US SEER-Medicare reported that men undergoing biopsy were 2.26 times more likely to be hospitalized for infectious complications within 30 days compared with randomly selected controls. The factors predicting a higher susceptibility to infection remain largely unknown but some authors have higlighted in the etiopathogenesis the importance of the augmented prevalence of ciprofloxacin resistant variant of bacteria in the rectum flora. We present one case of sepsis after transrectal prostate biopsy in a patient with history of pancreatic surgery. Based on our experience patients candidated to prostate biopsy with transrectal technique with history of recent major surgery represent an high risk category for infective complication. Also major pancreatic surgery should be consider an high risk category for infection. A transperineal approach and preventive measures (such as rectal swab) should be adopted to reduce biopsy driven infection.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / adverse effects*
  • Biopsy / adverse effects
  • Biopsy / methods
  • Drug Resistance, Bacterial
  • Escherichia coli Infections / chemically induced*
  • Escherichia coli Infections / epidemiology
  • Humans
  • Male
  • Middle Aged
  • Pancreatectomy*
  • Postoperative Complications / chemically induced*
  • Postoperative Complications / epidemiology
  • Prostate / pathology*
  • Rectum
  • Risk Assessment
  • Time Factors

Substances

  • Anti-Bacterial Agents